Suffering for Two: The Bind of Maternal Depression More women than ever are taking anti-depressant medication, including more pregnant women. But the FDA warns antidepressants may pose risks to babies. Not treating depression also poses risks. For American RadioWorks, Sasha Aslanian looks at the choices mothers face.
NPR logo

Suffering for Two: The Bind of Maternal Depression

  • Download
  • <iframe src="https://www.npr.org/player/embed/3869282/3870212" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Suffering for Two: The Bind of Maternal Depression

Suffering for Two: The Bind of Maternal Depression

Antidepressants Pose Uncertain Risks in Pregnant Women

Suffering for Two: The Bind of Maternal Depression

  • Download
  • <iframe src="https://www.npr.org/player/embed/3869282/3870212" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Participants in an experiment on how depression in mothers affects children. American RadioWorks hide caption

toggle caption
American RadioWorks

More women than ever are taking antidepressant medication, including more pregnant women. An advisory panel to the U.S. Food and Drug Administration wants to add a warning that some babies exposed to drugs like Prozac and Paxil during the last trimester of pregnancy developed tremors, jitteriness and even required hospitalization.

While the FDA negotiates with drugmakers over wording, Canada has moved ahead with similar warnings. But researchers warn that not treating depression also poses a risk to mother and child. Sasha Aslanian of American RadioWorks reports in this second of three stories on antidepressant drugs.